Whitehawk Therapeutics, Inc
Advertisement
Whitehawk Therapeutics, Inc., based in Morristown, NJ, is dedicated to advancing antibody drug conjugate (ADC) therapies aimed at treating difficult-to-treat cancers. The company focuses on innovative tumor targeting and clinical strategies to enhance therapeutic outcomes for patients with significant unmet medical needs.
Employing a next-generation ADC platform, Whitehawk Therapeutics seeks to address the limitations of first-generation therapies by offering improved stability and targeting capabilities. Their pipeline includes three ADC assets primarily focused on lung and gynecological cancers, leveraging clinically validated proteins that are widely expressed across various tumor types.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
Advertisement
